Haemonetics (HAE) Price to Earnings (2009 - 2026)

Haemonetics has reported Price to Earnings for 18 years, with the latest figure at 106.58 in Q2 2026.

• On a quarterly basis, Price to Earnings rose 2.05% year-over-year to 106.58 in Q2 2026; TTM through Jun 2026 was 36.5, a 67.73% increase from a year earlier, with the FY2026 full-year figure at 25.13, up 38.31% from the prior year.
• Price to Earnings was 106.58 for Q2 2026 at Haemonetics, up from 121.54 in the prior quarter.
• The five-year high for Price to Earnings was 334.01 in Q2 2022, with the low at 121.54 in Q1 2026.
• Average Price to Earnings over 5 years is 118.77, with a median of 112.98 recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Price to Earnings surged 164.71% in 2022, then tumbled 331.29% in 2026.
• Over 5 years, Price to Earnings stood at 120.5 in 2022, then grew by 15.4% to 139.06 in 2023, then declined by 25.26% to 103.93 in 2024, then fell by 19.15% to 84.03 in 2025, then increased by 26.84% to 106.58 in 2026.
• The last three Price to Earnings figures came in at 106.58 (Q2 2026), 121.54 (Q1 2026), and 84.03 (Q4 2025), per Business Quant data.